Shares of Theratechnologies jumped after the company received Food and Drug Administration approval for Egrifta WR, its treatment for excess abdominal fat in adults with HIV and lipodystrophy.

New, improved formulation set to replace EGRIFTA SV®MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or ...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...

Approach could herald new way of delivering drugs beyond birth control — such as for HIV, TB, schizophrenia, chronic pain, or metabolic disease​ — over long periods of time ...

For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a ...

First-in-human studies anticipated to begin in 2026Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of ...

Engineers devised a way to deliver drugs such as contraceptives by injecting them as suspended crystals. Once under the skin, the crystals assemble into a drug depot that can last for months or years, ...

MIT researchers have devised a way to deliver drugs in higher concentration with less pain. They injected the drug as a ...